OppenheimerFunds’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,500
Closed -$221K 1872
2016
Q4
$221K Buy
+6,500
New +$751K ﹤0.01% 1712
2015
Q4
Sell
-201,000
Closed -$105K 1751
2015
Q3
$105K Buy
+201,000
New +$19.4M ﹤0.01% 924
2013
Q3
Sell
-1,500
Closed -$14K 942
2013
Q2
$14K Buy
+1,500
New +$127K ﹤0.01% 907

Other funds holding JNJ

OppenheimerFunds's JNJ Position: Q1 2019 in Review

OppenheimerFunds increased its Johnson & Johnson (JNJ) stake by 158% in Q1 2019, buying an estimated $47.5M and bringing the position to 579,800 shares worth $81.1M. The position accounts for 0.1% of the portfolio, ranked #210.

OppenheimerFunds first reported a position in JNJ in Q2 2013 and has held it in 24 quarters since. The position peaked at $619M in Q1 2016. 2,765 funds tracked by Wall St. Rank hold JNJ as of Q1 2019.

  • OppenheimerFunds held 579,800 shares of Johnson & Johnson worth $81.1M as of Q1 2019.
  • OppenheimerFunds bought 354,807 Johnson & Johnson shares in Q1 2019, an estimated $47.5M.
  • Johnson & Johnson made up 0.1% of OppenheimerFunds's portfolio in Q1 2019, its #210 holding.
  • OppenheimerFunds first reported a position in Johnson & Johnson in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Johnson & Johnson position peaked at $619M in Q1 2016.
  • 2,765 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.